trending Market Intelligence /marketintelligence/en/news-insights/trending/p-i3HvoboroBGfAwXCRajg2 content esgSubNav
In This List

OptimizeRx director resigns

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


OptimizeRx director resigns

OptimizeRx Corp. said board member Bryan Archambault resigned.

Archambault has been a director of the company since March. With the resignation, Archambault also resigned as a member of the board's audit, nomination and governance committees.

The Rochester, Mich.-based company said independent directors Patrick Spangler, James Lang and Ellen O'Connor Vos are expected to fill the roles left vacant by Archambault's departure.

The company operates a digital health messaging platform by using electronic health records to connect drugmakers with healthcare services providers.